Detection of SARS‐CoV‐2 in different human biofluids using the loop‐mediated isothermal amplification assay: A prospective diagnostic study in Fortaleza, Brazil. Issue 9 (20th May 2022)
- Record Type:
- Journal Article
- Title:
- Detection of SARS‐CoV‐2 in different human biofluids using the loop‐mediated isothermal amplification assay: A prospective diagnostic study in Fortaleza, Brazil. Issue 9 (20th May 2022)
- Main Title:
- Detection of SARS‐CoV‐2 in different human biofluids using the loop‐mediated isothermal amplification assay: A prospective diagnostic study in Fortaleza, Brazil
- Authors:
- Clementino, Marco
Cavalcante, Karene F.
Viana, Vania A. F.
Silva, Dayara de Oliveira
Damasceno, Caroline R.
Fernandes de Souza, Jessica
Gondim, Rafhaella N. D. G.
Jorge, Daniel M. de Melo
Magalhães, Lyvia M. V. C.
Arruda, Érico A. G. de
Neto, Roberto da J. P.
Medeiros, Melissa S.
Santos, Armênio A. dos
Magalhães, Pedro J. C.
Mello, Liana P.
Arruda, Eurico
Lima, Aldo Â. M.
Havt, Alexandre - Abstract:
- Abstract: We adopted the reverse‐transcriptase‐loop‐mediated isothermal amplification (RT‐LAMP) to detect severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) in patient samples. Two primer sets for genes N and Orf1ab were designed to detect SARS‐CoV‐2, and one primer set was designed to detect the human gene Actin . We collected prospective 138 nasopharyngeal swabs, 70 oropharyngeal swabs, 69 salivae, and 68 mouth saline wash samples from patients suspected to have severe acute respiratory syndrome (SARS) caused by SARS‐CoV‐2 to test the RT‐LAMP in comparison with the gold standard technique reverse‐transcription quantitative polymerase chain reaction (RT‐qPCR). The accuracy of diagnosis using both primers, N5 and Orf9, was evaluated. Sensitivity and specificity for diagnosis were 96% (95% confidence interval [CI]: 87–99) and 85% (95% CI: 76–91) in 138 samples, respectively. Accurate diagnosis results were obtained only in nasopharyngeal swabs processed via extraction kit. Accurate and rapid diagnosis could aid coronavirus disease 2019 (COVID‐19) pandemic management by identifying, isolating, and treating patients rapidly.
- Is Part Of:
- Journal of medical virology. Volume 94:Issue 9(2022)
- Journal:
- Journal of medical virology
- Issue:
- Volume 94:Issue 9(2022)
- Issue Display:
- Volume 94, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 94
- Issue:
- 9
- Issue Sort Value:
- 2022-0094-0009-0000
- Page Start:
- 4170
- Page End:
- 4180
- Publication Date:
- 2022-05-20
- Subjects:
- coronavirus -- molecular diagnosis -- RT‐LAMP
Virology -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9071 ↗
http://www.interscience.wiley.com/jpages/0146-6615 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmv.27842 ↗
- Languages:
- English
- ISSNs:
- 0146-6615
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5017.095000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22588.xml